This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Oxthera Intellectual Property Ab, Oxthera Intellectual Property. Active years: 2018-2021.
Company Filing History:
Years Active: 2018-2021
Title: Maria Åkerman: Innovator in Oxalate-Related Treatments
Introduction
Maria Åkerman is a notable inventor based in Sollentuna, Sweden. She has made significant contributions to the field of medical treatments related to oxalate-related disorders. With a total of 3 patents, her work focuses on innovative solutions for managing oxalate imbalances in patients.
Latest Patents
One of her latest patents is titled "Secretagogues derived from oxalobacter formigenes." This invention relates to a secretagogue compound derived from oxalate-degrading bacteria, aimed at treating oxalate-related diseases. The administration of this secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. Additionally, the patent includes a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate-related disease, and a method for preparing a secretagogue. Another significant patent is "Compositions and methods for the treatment or prevention of oxalate-related disorders." This disclosure pertains to pharmaceutical compositions and methods for treating and/or preventing oxalate-related disorders, particularly suitable for late-stage hyperoxaluria characterized by high plasma-oxalate levels and a decrease in kidney function.
Career Highlights
Throughout her career, Maria has worked with companies such as Oxthera Intellectual Property AB and Oxthera Intellectual Property. Her innovative approaches have positioned her as a key figure in the development of treatments for oxalate-related conditions.
Collaborations
Maria has collaborated with notable coworkers, including Elisabeth Lindner and Helena Cowley. Their combined expertise has contributed to the advancement of research in this specialized field.
Conclusion
Maria Åkerman's contributions to the treatment of oxalate-related disorders highlight her innovative spirit and dedication to improving patient outcomes. Her patents and collaborations reflect her commitment to advancing medical science.